The Effectiveness of Lactobacillus Beverages in Controlling Infections among the Residents of an Aged Care Facility: A Randomized Placebo-Controlled Double-Blind Trial

Annals of Nutrition and Metabolism

Volumn 68, Issue 1, 2016, Pages 51-59

  Nagata, Satoru ^a,b   Asahara, Takashi ^c   Wang, Chongxin ^b   Suyama, Yumi ^c   Chonan, Osamu ^c   Takano, Kikuo ^d   Daibou, Masashi ^d   Takahashi, Takuya ^c   Nomoto, Koji ^c   Yamashiro, Yuichiro ^b  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b JUNTENDO UNIVERSITY   (Japan)

^c YAKULT CENTRAL INSTITUTE FOR MICROBIOLOGICAL RESEARCH   (Japan)

^d Seikei kai Hospital Group   (Japan)

Author keywords

Aged care facility residents; Bowel movements; Fecal microbiota; Infection control; Lactobacillus casei strain Shirota

Indexed keywords

ACETIC ACID; PROBIOTIC AGENT;

ADULT; AGED; BEVERAGE; BIFIDOBACTERIUM; BODY MASS; CHEMISTRY; COMMUNICABLE DISEASES; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FECES; FEMALE; FERMENTED MILK PRODUCT; HUMAN; ISOLATION AND PURIFICATION; LACTOBACILLUS CASEI; MALE; MICROBIOLOGY; MIDDLE AGED; PEPTOCLOSTRIDIUM DIFFICILE; PH; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; VERY ELDERLY;

ACETIC ACID; ADULT; AGED; AGED, 80 AND OVER; BEVERAGES; BIFIDOBACTERIUM; BODY MASS INDEX; CLOSTRIDIUM DIFFICILE; COMMUNICABLE DISEASES; CULTURED MILK PRODUCTS; DOUBLE-BLIND METHOD; FECES; FEMALE; HUMANS; HYDROGEN-ION CONCENTRATION; LACTOBACILLUS CASEI; MALE; MIDDLE AGED; PROBIOTICS; QUALITY OF LIFE;

EID: 84955673911     PISSN: 02506807     EISSN: 14219697     Source Type: Journal    
DOI: 10.1159/000442305     Document Type: Article

References (32)

1. Jakobsen R, Sørlie V: Dignity of older people in a nursing home: narratives of care providers. Nurs Ethics 2010;17:289-300.
2. Johanson JF, Irizarry F, Doughty A: Risk factors for fecal incontinence in a nursing home population. J Clin Gastroenterol 1997;24:156-160.
3. Gerba CP, Rose JB, Haas CN: Sensitive populations: who is at the greatest risk? Int J Food Microbiol 1996;30:113-123.
4. Strausbaugh LJ, Jacobson C, Sewell DL, Potter S, Ward TT: Antimicrobial therapy for methicillin-resistant Staphylococcus aureus colonization in residents and staff of a veterans affairs nursing home care unit. Infect Control Hosp Epidemiol 1992;13:151-159.
5. Weber DJ, Rutala WA, Miller MB, Huslage K, Sickbert-Bennett E: Role of hospital surfaces in the transmission of emerging health care-associated pathogens: norovirus, Clostridium difficile, and Acinetobacter species. Am J Infect Control 2010;38(5 suppl 1):S25-S33.
6. Takeda K, Suzuki T, Shimada SI, Shida K, Nanno M, Okumura K: Interleukin-12 is involved in the enhancement of human natural killer cell activity by Lactobacillus casei Shirota. Clin Exp Immunol 2006;146:109-115.
7. Sugawara G, Nagino M, Nishio H, Ebata T, Takagi K, Asahara T, Nomoto K, Nimura Y: Perioperative synbiotic treatment to prevent postoperative infectious complications in biliary cancer surgery: a randomized controlled trial. Ann Surg 2006;244:706-714.
8. Aso Y, Akaza H, Kotake T, Tsukamoto T, Imai K, Naito S: Preventive effect of a Lactobacillus casei preparation on the recurrence of superficial bladder cancer in a double-blind trial. The BLP Study Group. Eur Urol 1995;27:104-109.
9. Tamura M, Shikina T, Morihana T, Hayama M, Kajimoto O, Sakamoto A, Kajimoto Y, Watanabe O, Nonaka C, Shida K, Nanno M: Effects of probiotics on allergic rhinitis induced by Japanese cedar pollen: randomized double-blind, placebo-controlled clinical trial. Int Arch Allergy Immunol 2007;143:75-82.
10. Shimoyama T, Honi S, Tamura K, Yamamura M, Tanaka M, Yamazaki K: Microflora of patients with stool abnormality. Bifidobacteria Micoflora 1984;3:35-42.
11. Nagata S, Asahara T, Ohta T, Yamada T, Kondo S, Bian L, Wang C, Yamashiro Y, Nomoto K: Effect of the continuous intake of probiotic-fermented milk containing Lactobacillus casei strain Shirota on fever in a mass outbreak of norovirus gastroenteritis and the faecal microflora in a health service facility for the aged. Br J Nutr 2011;106:549-556.
12. Bian L, Nagata S, Asahara T, Rahman MS, Ohta T, Yuki N, Wang C, Takano K, Daibo M, Yamashiro Y, Nomoto K: Effects of continuous intake of Lactobacillus casei strain Shirota-fermented milk on risk management of long-term inpatients at health service facilities for the elderly. Int J Probiotics Prebiotics 2011;6:123-132.
13. Matsuda K, Tsuji H, Asahara T, Kado Y, Nomoto K: Sensitive quantitative detection of commensal bacteria by rRNA-targeted reverse transcription-PCR. Appl Environ Microbiol 2007;73:32-39.
14. Matsuda K, Tsuji H, Asahara T, Takahashi T, Kubota H, Nagata S, Yamashiro Y, Nomoto K: Sensitive quantification of Clostridium difficile cells by reverse transcription-quantitative PCR targeting rRNA molecules. Appl Environ Microbiol 2012;78:5111-5118.
15. Wada M, Lkhagvadorj E, Bian L, Wang C, Chiba Y, Nagata S, Shimizu T, Yamashiro Y, Asahara T, Nomoto K: Quantitative reverse transcription-PCR assay for the rapid detection of methicillin-resistant Staphylococcus aureus. J Appl Microbiol 2010;108:779-788.
16. Fujimoto J, Matsuki T, Sasamoto M, Tomii Y, Watanabe K: Identification and quantification of Lactobacillus casei strain Shirota in human feces with strain-specific primers derived from randomly amplified polymorphic DNA. Int J Food Microbiol 2008;126:210-215.
17. Kamiya S, Nagino M, Kanazawa H, Komatsu S, Mayumi T, Takagi K, Asahara T, Nomoto K, Tanaka R, Nimura Y: The value of bile replacement during external biliary drainage: an analysis of intestinal permeability, integrity, and microflora. Ann Surg 2004;239:510-517.
18. Darcy-Vrillon B, Cherbuy C, Morel MT, Durand M, Dueé PH: Short chain fatty acid and glucose metabolism in isolated pig colonocytes: modulation by NH4+. Mol Cell Biochem 1996;23:145-151.
19. Eklund T: The antimicrobial effect of dissociated and undissociated sorbic acid at different pH levels. J Appl Bacteriol 1983;54:383-389.
20. Fukuda S, Toh H, Hase K, Oshima K, Nakanishi Y, Yoshimura K, Tobe T, Clarke JM, Topping DL, Suzuki T, Taylor TD, Itoh K, Kikuchi J, Morita H, Hattori M, Ohno H: Bifidobacteria can protect from enteropathogenic infection through production of acetate. Nature 2011;469:543-547.
21. Nagao F, Nakayama M, Muto T, Okumura K: Effects of a fermented milk drink containing Lactobacillus casei strain Shirota on the immune system in healthy human subjects. Biosci Biotechnol Biochem 2000;64:2706-2708.
22. Matsuzaki T, Saito M, Usuku K, Nose H, Izumo S, Arimura K, Osame M: A prospective uncontrolled trial of fermented milk drink containing viable Lactobacillus casei strain Shirota in the treatment of HTLV-1 associated myelopathy/tropical spastic paraparesis. J Neurol Sci 2005;237:75-81.
23. Gleeson M, Bishop NC, Oliveira M, Tauler P: Daily probiotic's (Lactobacillus casei Shirota) reduction of infection incidence in athletes. Int J Sport Nutr Exerc Metab 2011;21:55-64.
24. Yokokura T, Yajima T, Hashimoto S: Effect of organic acid on gastrointestinal motility of rat in vitro. Life Sci 1977;21:59-62.
25. Kyne L, Hamel MB, Polavaram R, Kelly CP: Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile. Clin Infect Dis 2002;34:346-353.
26. Wada A, Masuda Y, Fukayama M, Hatakeyama T, Yanagawa Y, Watanabe H, Inamatsu T: Nosocomial diarrhoea in the elderly due to enterotoxigenic Clostridium perfringens. Microbiol Immunol 1996;40:767-771.
27. Hofstra H, Witholt B: Kinetics of synthesis, processing, and membrane transport of heat-labile enterotoxin, a periplasmic protein in Escherichia coli. J Biol Chem 1984;259:15182-15187.
28. Lin Z, Kotler DP, Schlievert PM, Sordillo EM: Staphylococcal enterocolitis: forgotten but not gone? Dig Dis Sci 2010;55:1200-1207.
29. Asahara T, Nomoto K, Shimizu K, Watanuki M, Tanaka R: Increased resistance of mice to Salmonella enterica serovar Typhimurium infection by synbiotic administration of bifidobacteria and transgalactosylated oligosaccharides. J Appl Microbiol 2001;91:985-996.
30. Asahara T, Shimizu K, Nomoto K, Watanuki M, Tanaka R: Antibacterial effect of fermented milk containing Bifidobacterium breve, Bifidobacterium bifidum and Lactobacillus acidophilus against indigenous Escherichia coli infection in mice. Microb Ecol Health Dis 2001;13:16-24.
31. Lkhagvadorj E, Nagata S, Wada M, Bian L, Wang C, Chiba Y, Yamashiro Y, Shimizu T, Asahara T, Nomoto K: Anti-infectious activity of synbiotics in a novel mouse model of methicillin-resistant Staphylococcus aureus infection. Microbiol Immunol 2010;54:265-275.
32. Ostling CE, Lindgren SE: Inhibition of enterobacteria and Listeria growth by lactic, acetic and formic acids. J Appl Bacteriol 1993;75:18-24.